This report provides a comprehensive analysis of the global Gel Card market, detailing its projected growth from 2025 through 2032. As essential diagnostic tools for immunohematology and blood typing, Gel Cards are seeing increased demand driven by advancements in transfusion safety, rising prevalence of blood disorders, and technological improvements in automation. The study offers detailed segmentation by type, application, and geography, while evaluating key market drivers, competitive landscapes, and strategic opportunities within the global healthcare sector.

Market Overview

Market Size and Forecast

The global Gel Card market is projected to grow from US$ 143 million in 2025 to US$ 231 million in 2032. The market is expected to expand at a Compound Annual Growth Rate (CAGR) of 7.3% from 2026 to 2032.

Product Definition

A Gel Card is a diagnostic tool utilized in immunohematology, specifically for blood typing and crossmatching procedures. It consists of a small plastic card containing multiple wells filled with a gel matrix. This gel matrix facilitates the separation and capture of cells based on their reactions with specific antigens or antibodies.

Market Dynamics Summary

The Gel Card market has experienced significant growth driven by advancements in diagnostic technologies, an increased demand for blood transfusion safety, and the rising necessity for precise and efficient testing methods within immunohematology. The utilization of Gel Cards is further propelled by growing awareness regarding the importance of blood compatibility testing, particularly in the field of transfusion medicine.

Market Drivers and Challenges

Key Market Drivers

• Rising Demand for Safe Blood Transfusions: An increasing number of surgeries, trauma cases, and medical treatments requiring blood transfusions necessitates safer and more compatible blood products. Gel Cards provide a reliable method for testing compatibility between donors and recipients, thereby reducing the risk of transfusion reactions.
• Technological Advancements: Continuous improvements in gel-based diagnostic technologies—including enhanced automation and more accurate antibody detection—drive market growth by improving the speed, accuracy, and reliability of blood typing and compatibility testing.
• Increasing Prevalence of Blood Disorders: The rising incidence of blood-related diseases, such as sickle cell disease, thalassemia, and anemia, along with the need for frequent transfusions, contributes to the growing demand for Gel Card products and blood testing.
• Government Regulations and Policies: Increasing emphasis from governments and regulatory bodies on improving blood transfusion safety leads to a higher demand for reliable blood typing technologies like Gel Cards.
• Population Growth and Aging: As the global population ages in both developed and developing nations, healthcare requirements—including blood transfusions—are increasing, which in turn boosts the demand for Gel Card products.

Market Challenges

• High Initial Cost: Although Gel Cards offer accurate and reliable results, their cost may be higher than traditional blood typing methods, potentially serving as a barrier for hospitals and smaller laboratories in developing regions.
• Competition: The immunohematology and blood typing market is highly competitive, with various companies offering alternative reagents and diagnostic technologies, such as microplate-based assays or tube testing.

Report Scope and Methodology

Research Scope

LP Information, Inc. (LPI) presents the “Gel Card Industry Forecast,” a newest research report that reviews total world Gel Card sales in 2025 and examines past sales. The report provides a comprehensive analysis of projected Gel Card sales from 2026 through 2032, broken down by market sector, region, and sub-sector, with detailed analysis provided in US$ millions.

Analytical Focus

This Insight Report provides a comprehensive analysis of the global Gel Card landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments and M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their market positions, geographic footprints, market entry strategies, and Gel Card portfolios and capabilities. This allows for a better understanding of how these firms maintain unique positions within an accelerating global market.

Methodology

The study utilizes a transparent methodology based on hundreds of qualitative and quantitative bottom-up market inputs. This approach offers a highly nuanced view of the current state and future trajectory of the global Gel Card market, evaluating key trends, drivers, and factors shaping the global outlook. The forecast is broken down by geography, market size, application, and type to identify emerging pockets of opportunity.

Market Segmentation

Segmentation by Type

• Grouping Gel Card
• Crossmatch Gel Card
• Antibody Screening Gel Card
• Others

Segmentation by Application

• Hospital
• Clinic
• Others

Segmentation by Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their market penetration, product portfolio, and company coverage:

• Aikang MedTech
• Bio-Rad
• Biorex Diagnostics
• BSBE
• Fortress Diagnostics
• Grifols
• ISLAB
• KangJia
• Ortho Clinical Diagnostics
• Tulip Diagnostics
• Zhuhai Ideal Biotech

Key Questions Addressed

• What is the 10-year outlook for the global Gel Card market?
• What factors are driving Gel Card market growth, both globally and by region?
• Which technologies are poised for the fastest growth by region and market?
• How do Gel Card market opportunities vary by end market size?
• How does the Gel Card market break out by Application and Type?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Gel Card Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Gel Card by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Gel Card by Country/Region, 2021, 2025 & 2032

  • 2.2 Gel Card Segment by Type

    • 2.2.1 Grouping Gel Card

    • 2.2.2 Crossmatch Gel Card

    • 2.2.3 Antibody Screening Gel Card

    • 2.2.4 Others

    • 2.2.5 Gel Card Sales by Type

      • 2.2.5.1 Global Gel Card Sales Market Share by Type (2021-2026)
      • 2.2.5.2 Global Gel Card Revenue and Market Share by Type (2021-2026)
      • 2.2.5.3 Global Gel Card Sale Price by Type (2021-2026)

  • 2.3 Gel Card Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Others

    • 2.3.4 Gel Card Sales by Application

      • 2.3.4.1 Global Gel Card Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Gel Card Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Gel Card Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Gel Card Breakdown Data by Company

    • 3.1.1 Global Gel Card Annual Sales by Company (2021-2026)

    • 3.1.2 Global Gel Card Sales Market Share by Company (2021-2026)

  • 3.2 Global Gel Card Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Gel Card Revenue by Company (2021-2026)

    • 3.2.2 Global Gel Card Revenue Market Share by Company (2021-2026)

  • 3.3 Global Gel Card Sale Price by Company

  • 3.4 Key Manufacturers Gel Card Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Gel Card Product Location Distribution

    • 3.4.2 Players Gel Card Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Gel Card by Geographic Region

  • 4.1 World Historic Gel Card Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Gel Card Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Gel Card Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Gel Card Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Gel Card Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Gel Card Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Gel Card Sales Growth

  • 4.4 APAC Gel Card Sales Growth

  • 4.5 Europe Gel Card Sales Growth

  • 4.6 Middle East & Africa Gel Card Sales Growth

• 5 Americas

  • 5.1 Americas Gel Card Sales by Country

    • 5.1.1 Americas Gel Card Sales by Country (2021-2026)

    • 5.1.2 Americas Gel Card Revenue by Country (2021-2026)

  • 5.2 Americas Gel Card Sales by Type (2021-2026)

  • 5.3 Americas Gel Card Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Gel Card Sales by Region

    • 6.1.1 APAC Gel Card Sales by Region (2021-2026)

    • 6.1.2 APAC Gel Card Revenue by Region (2021-2026)

  • 6.2 APAC Gel Card Sales by Type (2021-2026)

  • 6.3 APAC Gel Card Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Gel Card by Country

    • 7.1.1 Europe Gel Card Sales by Country (2021-2026)

    • 7.1.2 Europe Gel Card Revenue by Country (2021-2026)

  • 7.2 Europe Gel Card Sales by Type (2021-2026)

  • 7.3 Europe Gel Card Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Gel Card by Country

    • 8.1.1 Middle East & Africa Gel Card Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Gel Card Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Gel Card Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Gel Card Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Gel Card

  • 10.3 Manufacturing Process Analysis of Gel Card

  • 10.4 Industry Chain Structure of Gel Card

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Gel Card Distributors

  • 11.3 Gel Card Customer

• 12 World Forecast Review for Gel Card by Geographic Region

  • 12.1 Global Gel Card Market Size Forecast by Region

    • 12.1.1 Global Gel Card Forecast by Region (2027-2032)

    • 12.1.2 Global Gel Card Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Gel Card Forecast by Type (2027-2032)

  • 12.7 Global Gel Card Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Grifols

    • 13.1.1 Grifols Company Information

    • 13.1.2 Grifols Gel Card Product Portfolios and Specifications

    • 13.1.3 Grifols Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Grifols Main Business Overview

    • 13.1.5 Grifols Latest Developments

  • 13.2 Fortress Diagnostics

    • 13.2.1 Fortress Diagnostics Company Information

    • 13.2.2 Fortress Diagnostics Gel Card Product Portfolios and Specifications

    • 13.2.3 Fortress Diagnostics Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Fortress Diagnostics Main Business Overview

    • 13.2.5 Fortress Diagnostics Latest Developments

  • 13.3 Ortho Clinical Diagnostics

    • 13.3.1 Ortho Clinical Diagnostics Company Information

    • 13.3.2 Ortho Clinical Diagnostics Gel Card Product Portfolios and Specifications

    • 13.3.3 Ortho Clinical Diagnostics Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Ortho Clinical Diagnostics Main Business Overview

    • 13.3.5 Ortho Clinical Diagnostics Latest Developments

  • 13.4 ISLAB

    • 13.4.1 ISLAB Company Information

    • 13.4.2 ISLAB Gel Card Product Portfolios and Specifications

    • 13.4.3 ISLAB Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 ISLAB Main Business Overview

    • 13.4.5 ISLAB Latest Developments

  • 13.5 Biorex Diagnostics

    • 13.5.1 Biorex Diagnostics Company Information

    • 13.5.2 Biorex Diagnostics Gel Card Product Portfolios and Specifications

    • 13.5.3 Biorex Diagnostics Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Biorex Diagnostics Main Business Overview

    • 13.5.5 Biorex Diagnostics Latest Developments

  • 13.6 Bio-Rad

    • 13.6.1 Bio-Rad Company Information

    • 13.6.2 Bio-Rad Gel Card Product Portfolios and Specifications

    • 13.6.3 Bio-Rad Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Bio-Rad Main Business Overview

    • 13.6.5 Bio-Rad Latest Developments

  • 13.7 Tulip Diagnostics

    • 13.7.1 Tulip Diagnostics Company Information

    • 13.7.2 Tulip Diagnostics Gel Card Product Portfolios and Specifications

    • 13.7.3 Tulip Diagnostics Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Tulip Diagnostics Main Business Overview

    • 13.7.5 Tulip Diagnostics Latest Developments

  • 13.8 KangJia

    • 13.8.1 KangJia Company Information

    • 13.8.2 KangJia Gel Card Product Portfolios and Specifications

    • 13.8.3 KangJia Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 KangJia Main Business Overview

    • 13.8.5 KangJia Latest Developments

  • 13.9 Aikang MedTech

    • 13.9.1 Aikang MedTech Company Information

    • 13.9.2 Aikang MedTech Gel Card Product Portfolios and Specifications

    • 13.9.3 Aikang MedTech Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Aikang MedTech Main Business Overview

    • 13.9.5 Aikang MedTech Latest Developments

  • 13.10 Zhuhai Ideal Biotech

    • 13.10.1 Zhuhai Ideal Biotech Company Information

    • 13.10.2 Zhuhai Ideal Biotech Gel Card Product Portfolios and Specifications

    • 13.10.3 Zhuhai Ideal Biotech Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Zhuhai Ideal Biotech Main Business Overview

    • 13.10.5 Zhuhai Ideal Biotech Latest Developments

  • 13.11 BSBE

    • 13.11.1 BSBE Company Information

    • 13.11.2 BSBE Gel Card Product Portfolios and Specifications

    • 13.11.3 BSBE Gel Card Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 BSBE Main Business Overview

    • 13.11.5 BSBE Latest Developments

• 14 Research Findings and Conclusion